Lerner et al Nature vol. 299: 592-596, 1982.* |
marglin et al Ann Rev Biochemistry vol. 39: 841-866, 1970.* |
Galfre et al Methods in Enzymology vol. 73 1-46, 1981.* |
Harlow et al. Antibodies A Laboratory Manual, CSHL Press 1988, pp. 285-287.* |
Harris et al. TIBTECHII:42-44, 1993.* |
Baggiolini et al., Interleukin-8, a chemotactic and inflammatory cytokine, (1992) Fed. of Euro. Biochem. Soc., 307:97-101. |
Bazzoni, F. et al., Phagocytosing neutrophils produce and release high amounts of the neutrophil-activating peptide 1/interleukin, (1991) J. Exp. Med. 173:771-774. |
Gayle et al., Importance of the amino terminus of the Interleukin-8 receptor in ligand interactions, J. Biol. Chem. (1993) 268:7283-7289. |
Geiser et al., The interleukin-8-related chemotactic cytokines GROα, GROβ, and GROγ activate human neutrophil and basophil leukocytes, J. Biol. Chem. (1992) 206:15419-15324. |
Holmes et al., Structure and functional expression of a human interleukin-8 receptorScience (1991) 253:1278-1280. |
LaRosa et al., Amino terminus of the Interleukin-8 receptor is a major determinant of receptor subtype specificity, J. Biol. Chem. (1992) 267:25402-25406. |
Larson, C.G. et al., The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes, (1989) Science 243:1464-1466. |
Lewis, M., et al., Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific, (1991), Proc. Natl. Acad. Sci USA, 88:2830-2834. |
Matsushima, K. et al., Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor, (1988) J. Exp. Med. 167:1883-1893. |
Moser, B. et al., Neutrophil-activating peptide 2 and gro/melanoma growth-stimulatory activity interact with neutrophil-activating peptide 1/interleukin 8 receptors on human neutrophils, (1991) J. Biol. Chem. 266:10666-10671. |
Mukaida, N. et al., Genomic structure of the human monocyte-derived neutrophil chemotactic factor IL-8, (1989) J. Immunol. 143:1366-1371. |
Ribeiro, R.A. et al., IL-8 causes in vivo neutrophilmigration by a cell-dependent mechanism, (1991) Immunology 73:472-477. |
Schröder, J.M. et al., Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity, (1987) J. Immunol. 139:3474-3483. |
Schröder, J.M. et al., Purification and partial biologic characterization of a human lymphocyte-derived peptide with potent neutrophil-stimulating activity (1988) J. Immunol. 140:3534-3540. |
Schröder, J.M., The monocyte-derived neutrophil activating peptide (NAP/Interleukin 8) stimulates human neutrophil arachidonate-5-lipoxygenase, but not the release of cellular arachidonate, (1989) J. Exp. Med. 170:847-861. |
Suzuki, K. et al., Purification and partial primary sequence of a chemotactic protein for polymorphonuclear leukocytes derived from human lung giant cell carcinoma LU65C cells, (1989) J. Exp. Med. 169:1895-1901. |
Van Damme, J. et al., A novel, NH2-terminal sequence-characterized human monokine possessing neutrophil chemotactic, skin-reactive, and granulocytosis-promoting activity, (1988) J. Exp. Med. 167:1364-1376; and |
Walz A., et al., Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin 8, (1991) J. Exp. Med. 174:1355-1362. |